Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

  • February 23, 2024

Recognising the critical importance of collaboration and advocacy behind the scenes, the NECA Team embraces the opportunity to contribute to shaping the landscape for Neuroendocrine Cancer patients.

By sitting on this group of diverse boards, working and study groups, the team ensures a comprehensive and informed approach to addressing the unique challenges faced by individuals diagnosed with neuroendocrine cancer.

  • Cancer Nurses Association of Australia (CNSA) – Vice President, Board of Directors
  • Coalition of National Nursing Organisations (CoNNMO) – Council
  • Alliance & Partnerships for Patient Innovation & Solutions (APPIS) – Council, Expert Advisory Panel
  • International Neuroendocrine Cancer Alliance (INCA) – Board of Directors, Chair of Research Committee
  • Australian Cancer Nurse Navigation Program – Expert Advisory Group, Telehealth Nurse Working Group
  • NSW Health Consumers  – Consumer Organisations Taskforce
  • Cancer Organisations Collaboration – representative Non Government organisations
  • The Australasian Association of Nuclear Medicine Specialists (AANMS) Theranostics Meeting
  • Commonwealth Neuroendocrine Tumour research collaborative (CommNETs) Working Group
  • AUSNET Study Group
  • North Foundation Development Committee
  • NET Nurse Special Interest Group

Through these collaborative efforts, the NECA Team aims to amplify the voices of patients and advocate for improved resources, research, and support networks.

The NECA Team extends gratitude to the boards and their members for the opportunity to contribute to the collective mission of enhancing the lives of Neuroendocrine Cancer patients.

As the advocacy journey continues, the NECA Team remains steadfast in its commitment to making a meaningful impact and fostering positive change within the Neuroendocrine Cancer community.

Share this post

Recent posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

February 9, 2026

Australia delivers excellent cancer care, but not equally

February 4, 2026

NECA Contributes to Multidisciplinary Systemic Review

January 28, 2026

AUS-NET Update, January 2026

January 20, 2026
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousTamworth local Ryan Harding advocates for VHL patients to have access to Belzutifan
NextThe David Trophy 2024Next

Related Posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Thank you to NET patient Kristen Leknius for hosting a neuroendocrine cancer information table at the February Peninsula Bays Hospital Wellness Day. With around 250

Australia delivers excellent cancer care, but not equally

Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer

NECA Contributes to Multidisciplinary Systemic Review

NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on

AUS-NET Update, January 2026

The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin